Print page

Home » IFPAC: Ritchie and Van Trieste of Amgen

IFPAC: Ritchie and Van Trieste of Amgen

Gary Ritchie’s chat with Amgen’s Martin Van Trieste about Rx360, a new global anticounterfeiting consortium

More content on this topic:

  • Featured White Papers